TrialAnnals of the rheumatic diseases2007

Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial.

D D Gladman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.